Press Releases

Newsroom
In the News
Press Releases
Resources for Journalists

Press Releases

Share
Share
and/or
498 News Releases found
MSK's David Pfister, Nancy Lee, and Richard Wong
Memorial Sloan Kettering Cancer Center Ranked #1 Nationally for Ear, Nose, and Throat Care by U.S. News & World Report

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number one center for ear, nose, and throat care by U.S. News & World Report. MSK has been consistently ranked among the top two cancer centers in the country for over 30 years.
MSK Awards & Appointments

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Crain’s New York Business 2021 Notable in Health Care honorees
MSK Leaders Recognized in Crain’s New York Business 2021 Notable in Health Care List

Dr. Craig Thompson, Dr. Peter Bach, Dr. Ushma Neill, and Dr. William Rosa were recognized for their professional, civic, and philanthropic achievements.
Participants rode at Cycle for Survival’s first ever socially distant outdoor ride at MetLife Stadium in New Jersey. 
Cycle for Survival Raises $285 Million in 15 Years

With founding partner Equinox, Cycle for Survival surpasses $285 million raised since 2007; every dollar funds rare cancer research led by Memorial Sloan Kettering Cancer Center.
MSK Awards & Appointments

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
MSK leadership applauding for graduates
Marking the Milestone, Celebrating the Achievement: MSK Kids Hosts 15th Annual Pediatric Convocation

For the 15th year, MSK honored the academic achievements of our youngest patients by hosting MSK Kids Convocation - a virtual ceremony to help mark and celebrate the end of their adolescent school years.
Michael Morris, MD
ASCO 2021: PSMA-Targeted Radioligand Therapy Improves Survival in Metastatic Prostate Cancer

New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC).
Morris, Wolchok, Schram, D'Angelo
ASCO 2021: MSK Experts Featured at the American Society of Clinical Oncology Annual Meeting

The 2021 ASCO Annual Meeting will bring together one of the largest, most diverse audiences in oncology and provide engaging broadcast and on-demand presentations of the latest cutting-edge oncology research. ASCO 2021 will focus on Equity: Every Patient. Every Day. Everywhere.
Dean Bajorin, MD
Immunotherapy after Bladder Cancer Surgery May Reduce Recurrence, Study Shows

New research from Memorial Sloan Kettering Cancer Center (MSK) medical oncologist Dean Bajorin, MD, and colleagues found that patients who received nivolumab (Opdivo®) after bladder cancer surgery reduced their overall risk for high-grade bladder cancer recurrence. This research was published today in the New England Journal of Medicine.